Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Sep;23(9):1425-31.
doi: 10.1007/s00467-008-0820-3. Epub 2008 May 21.

Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome

Affiliations
Review

Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome

C Mark Taylor. Pediatr Nephrol. 2008 Sep.

Abstract

Haemolytic uraemic syndrome (HUS) can be classified according to the aetiology of the different disorders from which it is composed. The most prevalent form is that induced by shigatoxin producing Escherichia coli (STEC) and, in some tropical regions, by Shigella dysenteriae type 1. STEC cause a zoonosis, are widely distributed in nature, enter the food chain in different ways, and show regional differences. Not all STEC are human pathogens. Enterohaemorrhagic E. coli usually cause attachment and effacing lesions in the intestine. This is not essential, but production of a shigatoxin (Stx) is. Because Stx are encoded by a bacteriophage, this property is transferable to naïve strains. Laboratory methods have improved by identifying STEC either via the toxin or its bacteriophage. Shigella dysenteriae type 1 produces shigatoxin, identical to Stx-1, but also has entero-invasive properties that enterohaemorrhagic Escherichia coli (EHEC) do not. Shigella patients risk bacteremia and benefit from early antibiotic treatment, unlike those with EHEC.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423–431. - PubMed
    1. Dolislager D, Tune B. The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome. Arch Pediatr Adolesc Med. 1978;132:55–58. - PubMed
    1. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GC, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985;151:775–782. - PubMed
    1. Milford DV, Taylor CM, Gutridge B, Hall SM, Rowe B, Kleanthous H. Haemolytic uraemic syndrome in the British Isles, 1985–8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch Dis Child. 1990;65:716–721. - PMC - PubMed
    1. Kleantous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV. Haemolytic uraemic syndrome in the British Isles, 1985–8: association with verocytotoxin producing Escherichia coli. Part 2: microbiological aspects. Arch Dis Child. 1990;65:722–727. - PMC - PubMed

MeSH terms